Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis
OBJECTIVES: Understanding COVID-19 vaccine hesitancy among migrant and refugee groups is critical for achieving vaccine equity. Therefore, we aimed to estimate the prevalence of COVID-19 vaccine acceptance among migrant and refugee populations. METHODS: A systematic review (PROSPERO: CRD42022333337)...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163798/ https://www.ncbi.nlm.nih.gov/pubmed/37223070 http://dx.doi.org/10.1016/j.jvacx.2023.100308 |
_version_ | 1785037958849495040 |
---|---|
author | Alimoradi, Zainab Sallam, Malik Jafari, Elahe Potenza, Marc N. Pakpour, Amir H. |
author_facet | Alimoradi, Zainab Sallam, Malik Jafari, Elahe Potenza, Marc N. Pakpour, Amir H. |
author_sort | Alimoradi, Zainab |
collection | PubMed |
description | OBJECTIVES: Understanding COVID-19 vaccine hesitancy among migrant and refugee groups is critical for achieving vaccine equity. Therefore, we aimed to estimate the prevalence of COVID-19 vaccine acceptance among migrant and refugee populations. METHODS: A systematic review (PROSPERO: CRD42022333337) was conducted (December 2019–July 2022) using PubMed, Scopus, Web of Science, ProQuest and Google Scholar. RESULTS: Nineteen studies from 12 countries were included. The pooled estimated prevalence of COVID-19 vaccine willingness among migrant and refugee groups was 70% (19 studies, 95% CI: 62.3–77.4%, I(2): 99.19%, τ(2): 0.03). Female and male participants did not differ significantly with each other (p = 0.64). Although no individual variable contributed statistically significantly in multivariable meta-regression analysis, the multivariable model that considered methodological quality, mean age of participants, participant group and country of origin explained 67% of variance. DISCUSSION: Proportions of migrant/refugee groups receiving COVID-19 vaccinations approximated those observed among general populations. Additional studies are needed to examine factors relating to vaccine willingness to identify the most significant factors that may be targeted in interventions. |
format | Online Article Text |
id | pubmed-10163798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101637982023-05-08 Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis Alimoradi, Zainab Sallam, Malik Jafari, Elahe Potenza, Marc N. Pakpour, Amir H. Vaccine X Review OBJECTIVES: Understanding COVID-19 vaccine hesitancy among migrant and refugee groups is critical for achieving vaccine equity. Therefore, we aimed to estimate the prevalence of COVID-19 vaccine acceptance among migrant and refugee populations. METHODS: A systematic review (PROSPERO: CRD42022333337) was conducted (December 2019–July 2022) using PubMed, Scopus, Web of Science, ProQuest and Google Scholar. RESULTS: Nineteen studies from 12 countries were included. The pooled estimated prevalence of COVID-19 vaccine willingness among migrant and refugee groups was 70% (19 studies, 95% CI: 62.3–77.4%, I(2): 99.19%, τ(2): 0.03). Female and male participants did not differ significantly with each other (p = 0.64). Although no individual variable contributed statistically significantly in multivariable meta-regression analysis, the multivariable model that considered methodological quality, mean age of participants, participant group and country of origin explained 67% of variance. DISCUSSION: Proportions of migrant/refugee groups receiving COVID-19 vaccinations approximated those observed among general populations. Additional studies are needed to examine factors relating to vaccine willingness to identify the most significant factors that may be targeted in interventions. Elsevier 2023-05-06 /pmc/articles/PMC10163798/ /pubmed/37223070 http://dx.doi.org/10.1016/j.jvacx.2023.100308 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Alimoradi, Zainab Sallam, Malik Jafari, Elahe Potenza, Marc N. Pakpour, Amir H. Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis |
title | Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis |
title_full | Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis |
title_fullStr | Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis |
title_full_unstemmed | Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis |
title_short | Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis |
title_sort | prevalence of covid-19 vaccine acceptance among migrant and refugee groups: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163798/ https://www.ncbi.nlm.nih.gov/pubmed/37223070 http://dx.doi.org/10.1016/j.jvacx.2023.100308 |
work_keys_str_mv | AT alimoradizainab prevalenceofcovid19vaccineacceptanceamongmigrantandrefugeegroupsasystematicreviewandmetaanalysis AT sallammalik prevalenceofcovid19vaccineacceptanceamongmigrantandrefugeegroupsasystematicreviewandmetaanalysis AT jafarielahe prevalenceofcovid19vaccineacceptanceamongmigrantandrefugeegroupsasystematicreviewandmetaanalysis AT potenzamarcn prevalenceofcovid19vaccineacceptanceamongmigrantandrefugeegroupsasystematicreviewandmetaanalysis AT pakpouramirh prevalenceofcovid19vaccineacceptanceamongmigrantandrefugeegroupsasystematicreviewandmetaanalysis |